|Bid||5.00 x 2200|
|Ask||5.44 x 2200|
|Day's range||5.01 - 5.19|
|52-week range||4.52 - 16.90|
|Beta (5Y monthly)||-0.31|
|PE ratio (TTM)||28.44|
|Earnings date||20 Feb 2024 - 26 Feb 2024|
|Forward dividend & yield||N/A (N/A)|
|1y target est||9.11|
Investors need to pay close attention to Maravai LifeSciences (MRVI) stock based on the movements in the options market lately.
One thing we could say about the analysts on Maravai LifeSciences Holdings, Inc. ( NASDAQ:MRVI ) - they aren't...
SAN DIEGO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conferences during the month of November. On November 14, 2023, at 10:55 a.m. EST, Trey Martin, Chief Executive Officer (CEO) and Kevin Herde, Chief Financial Officer (CFO), will participate in a fireside chat at the Stifel Healthcare Conference, 2023, being held